CAS: 262438-43-7 - ATN-161
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ATN-161 REF: IN-DA00BF27CAS: 262438-43-7 | 98% | 54.00 €~191.00 € | Tue 14 Jan 25 |
 | ATN 161 REF: 3D-MKA43843CAS: 262438-43-7 | Min. 95% | To inquire | Tue 25 Feb 25 |
 | ATN-161 REF: TM-T10398CAS: 262438-43-7 | 98% | 1,282.00 €~3,460.00 € | Tue 18 Mar 25 |
 | ATN 161 TFA Salt REF: TR-A790560CAS: 262438-43-7 | - - - | - - - | Discontinued product |
Ref: IN-DA00BF27
| 10mg | 54.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
ATN 161
CAS:262438-43-7
ATN 161 is a small molecule with anti-cancer properties. It binds to the Mcl-1 protein …
Formula:
C23H35N9O8S
Purity:
Min. 95%
Molecular weight:
597.65 g/mol
Ref: 3D-MKA43843
| 25mg | 875.00 € | ||
| 50mg | 1,317.00 € | ||
| 100mg | 1,832.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
ATN-161
CAS:262438-43-7
ATN-161 is a novel integrin α5β1 antagonist that inhibits angiogenesis and growth of liver metastases …
Formula:
C23H35N9O8S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
597.64
Ref: TM-T10398
| 25mg | 1,967.00 € | ||
| 50mg | 2,600.00 € | ||
| 100mg | 3,460.00 € |
Estimated delivery in United States, on Tuesday 18 Mar 2025
ATN 161 TFA Salt
CAS:262438-43-7
Applications ATN 161 is an α5β1 integrin inhibitor that has advanced to phase II clinical …
Formula:
C23H35N9O8S•x(CHF3O2)
Color and Shape:
White to Off-White Solid
Molecular weight:
597.65 + x(114.02)
Ref: TR-A790560
| 1mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information |
